Internal Medicine, Endocrinology, Diabetes, & Metabolism · Springfield, IL
NPI
1881652089
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
350 W Carpenter St
Springfield, IL, 62702
Phone (217) 528-7541
Groups this clinician bills Medicare through
Medicare paid, 2024
$148K
6,378 services
Medicare patients, 2024
538
Average age 73
Drug cost, 2024
$3.8M
9,635 prescriptions
Company payments, 2025
$292
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin D Hazard was code J0897 (injection, denosumab, 1 mg), 3,000 times for 34 patients. In total Kevin D Hazard billed 6,378 services in 35 codes, and Medicare paid $148K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,000 | 34 | $20.23 | $61K |
| 99214 Office E&M - Established | Office | 407 | 245 | $89.56 | $36K |
| 36415 Venipuncture Blood Collection | Office | 384 | 269 | $8.25 | $3,167 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 299 | 239 | $12.50 | $3,739 |
| 95251 Test - Miscellaneous | Office | 191 | 108 | $24.50 | $4,680 |
| 99213 Office E&M - Established | Office | 150 | 144 | $59.08 | $8,862 |
| 96372 Injection Administration | Office | 81 | 38 | $9.41 | $762 |
| 99232 Hospital E&M - Subsequent | Facility | 27 | 16 | $59.05 | $1,594 |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 26 | 23 | $42.58 | $1,107 |
| 11721 Nail Procedure | Office | 24 | 11 | $28.71 | $689 |
| 83037 Blood Count | Office | 23 | 23 | $9.52 | $219 |
| 99204 Office E&M - New | Office | 13 | 13 | $93.38 | $1,214 |
By year: 2022 $151K for 4,275 services; 2023 $146K for 4,326 services; 2024 $148K for 6,378 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 384 | 269 | $8.25 | $3,167 |
| 83037 Blood Count | 23 | 23 | $9.52 | $219 |
Medicare prescription drug claims, 2024
In 2024, the drug Kevin D Hazard prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,155 prescriptions and refills. In total Kevin D Hazard wrote 9,635 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,155 | 2,992 | 287 | $9,803 |
| Ozempic Semaglutide | 469 | 744 | 103 | $722K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 465 | 1,074 | 149 | $74K |
| Mounjaro Tirzepatide | 431 | 515 | 87 | $534K |
| Metformin Hcl Er Metformin Hcl | 419 | 1,035 | 117 | $4,797 |
| Jardiance Empagliflozin | 351 | 690 | 84 | $408K |
| Metformin Hcl Generic | 333 | 836 | 98 | $2,486 |
| Novolog Flexpen Insulin Aspart | 227 | 527 | 97 | $84K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 214 | 577 | 89 | $28K |
| Atorvastatin Calcium Generic | 210 | 539 | 65 | $1,832 |
| Losartan Potassium Generic | 207 | 521 | 56 | $1,776 |
| Farxiga Dapagliflozin Propanediol | 193 | 355 | 52 | $191K |
| Synthroid Levothyroxine Sodium | 185 | 491 | 44 | $19K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 184 | 359 | 57 | $102K |
| Gabapentin Generic | 171 | 321 | 44 | $4,446 |
Brand drugs: 4,550 claims; generic drugs: 4,264 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin D Hazard $292 ($292 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbott Laboratories with $44.03.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 2 | $44.03 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $34.58 |
| Abbvie Inc. ABBV | 2 | $32.93 |
| Recor Medical Inc | 1 | $23.29 |
| Xeris Pharmaceuticals, Inc. | 1 | $21.56 |
| Dexcom, Inc. DXCM | 1 | $21.06 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $18.86 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $18.65 |
| Recordati_rare_diseases_inc. | 1 | $17.89 |
| Echosens North America, Inc. | 1 | $17.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.